TAIYO HOLDINGS CO., LTD. ("we" or "our") has identified its objectives as a corporate group in the Management Philosophy and Basic Management Policy below. The Group will develop by continuing the spirit of our management philosophy without changes and reviewing our basic management policy to match changes in the environment and strategy on a long-term basis.
We will realize "a pleasant society" by further advancing "every technology" the Group has and creating a wide range of products to help fulfill the dreams for the whole world with our innovative products.
- We will generate revenue and increase corporate value, thereby contributing to the well-being and prosperity of customers, communities, shareholders, and employees.
- We will discharge our corporate social responsibility with regard to the achievement of our management philosophy, including complying with the law, protecting the environment, ensuring thorough quality management, and contributing to society.
- We will leverage our global system to always provide superior products and services.
- We will constantly create opportunities for employees to challenge and develop themselves, aiming to have a corporate group composed of people who are highly motivated to be successful and to achieve goals set by themselves.
- We will increase our comprehensive corporate strengths by maximizing cooperation between the Group companies and strengthen the teamwork of all employees with emphasis on "speed and communication."
- We aim to have a group of global companies able to contribute to the realization of a pleasant society by constantly working for technological innovation and creating new products and businesses.
In our long-term management plan “Beyond Imagination 2030,” formulated in June 2021, we set out our “seven basic policies” and our goal, and established targets for 2030 of maintaining ROE of 18% and DOE (dividend on equity) of 5% or higher. While preserving financial soundness, we have sought to enhance capital efficiency and pursue sustainable growth through proactive shareholder returns. Reflecting these policies, in August 2025 we set new financial targets and established a Medium-term Management Plan that as the roadmap to 2030. With respect to ROE, we intend to raise the target to 30% in order to generate returns exceeding our cost of capital and to maximize capital efficiency. Going forward, in line with our long-term management plan and medium-term management plan, we will continue to strengthen existing businesses and execute our business strategies, create new businesses, and implement agile capital policies responsive to changes in the operating environment, thereby striving to enhance corporate value.
- Develop and utilize self-sufficient personnel capable of acting independently, who respond to diversifying organizations and societies
- Achieve continuous growth and explore new business areas in the electronics business
- Grow the medical and pharmaceuticals business further
- Transform and evolve through digital transformation
- Create new businesses
- Execute strategic M&A
- Strengthen efforts for SDGs (Sustainable Development Goals)
By 2030, with the evolution of technology, thoughts on the environment, and various initiatives around the world, a future will unfold that is beyond our imagination. We want to be a company that creates a wide range of innovative products to fulfill the dreams for such a future. Our self-sufficient personnel will further develop our core businesses of electronics, medical and pharmaceutical business, while continuing to work on our en ergy business and food business, even in such a dynamic environment. We will also actively explore new businesses.
Electronics Business
We aim to increase our market share for solder resist and to cr eate new businesses that will be the new pillar of profit following solder resist for other electronic materials business in 3 ways mainly - by strengthening the existing solder resist business (existing customers x existing technology), accelerati ng the continuous launch of new products (existing customers x new technologies), and promoting application develo pment (new customers x existing technologies).
Medical and Pharmaceuticals Business
The medical and pharmaceuticals business has grown as the secon d pillar of our company. In addition to the stable continuation of our pharmaceuticals manufacturing and sales bus iness, we will not only strengthen our domestic plants but also expand our business to overseas plants in the contract ed manufacturing business to provide high-quality products. In addition, we aim to further leap forward by expanding from a contract manufacturing organization (CMO) to contract development manufacturing organization (CDMO) by including drug development, and by the global expansion of CDMO in the fields of regenerative therapy and gene therapy.
Energy and Food Business
In the energy business, we are operating the domestic electroni cs materials business on 100% renewable energy, and in the future, we will further promote our efforts to reach 100% global ly. In the food business, anticipating the future food crisis, we will continue to carry out research and development.
Other Businesses
We will also actively wor k to create new businesses. In al l businesses, we wil l promote digital transformation (DX) through system development companies under the group and commercialize smart factory tools created from in-house DX as new products.
Since our founding in September 1953, our Group has developed with the trust of many stakeholders including shareholders, customers, business partners, and local communities. These efforts lead to the achievement of the “Sustainable Development Goals", and we will actively promote activities in the “Beyond Imagination 2030" as well. Based on our management philosophy “To achieve a cheerful society by further advancing every technology in our group and by creating a wide range of innovative products to fulfill the dreams of the world.” , we will promote the creation of the foundation for industrial and technological innovati on. We will continue our act ivities not only through the electronics business, but also through the medical and pharmaceuticals business and the floating solar power plants business, and as a company for a sustainable society.
Net sales 180 billion JPY Operating income 47 billion JPY
ROE 30 % (Return on Equity ratio)
DOE Maintain at least 5 % (Dividend on Equity ratio)